Stephen Liu
MD
Chief of Hematology and Oncology
Georgetown University
Sep 15, 2026
Episode
382
Soundcloud
Share
In this special WCLC 2026 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu recap key findings from day three of the conference, featuring major advances that move targeted therapies earlier in the treatment of lung cancer. Guests Dr. Roy Herbst, Dr. Julia Rotow, and Dr. Daniel Tan discuss new data from DESTINY-Lung04, ADAURA, and REZILIENT3 and what these findings could mean for clinical practice.
Guest
Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Julia Rotow
MD
Clinical Director and Research Director
Lowe Center for Thoracic Oncology
Dana-Faber Cancer Institute
Roy Herbst
MD
Director, Dartmouth Cancer Center
Professor, Geisel School of Medicine at Dartmouth
Daniel Tan
MD
Senior Consultant, Medical Oncology
National Cancer Centre Singapore
Professor, Duke-NUS Medical School
Senior Clinician-Scientist, Genome Institute of Singapore
